Legend: : Special Mention  : Important : Very Important : Key Development |
| |
 |
Laparoscopic exploration of common bile duct with primary closure versus T-tube drainage: a randomized clinical trial.
Zhang WJ, Xu GF, Wu GZ, Li JM, Dong ZT, Mo XD, J Surg Res. 2009 Nov;157(1):e1-5 |
| |
Early ductal decompression versus conservative management for gallstone pancreatitis with ampullary obstruction: a prospective randomized clinical trial.
JM Acosta, N Katkhouda, KA Debian, SG Groshen, DD Tsao-Wei, TV Berne, Ann Surg. 2006 Jan:33-40 |
| |
Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans.
HU Marschall, M Wagner, G Zollner, P Fickert, U Diczfalusy, J Gumhold, D Silbert, A Fuchsbichler, L Benthin, R Grundstr&oeig;m, U Gustafsson, S Sahlin, C Einarsson, M Trauner, Gastroenterology. 2005 Aug:476-85 |
| |
Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy.
NG Venneman, MG Besselink, YC Keulemans, GP Vanberge-Henegouwen, MA Boermeester, IA Broeders, PM Go, KJ van Erpecum, Hepatology. 2006 Jun:1276-83 |
| |
Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones.
MP Guarino, P Cong, M Cicala, R Alloni, S Carotti, J Behar, Gut. 2007 Jun:815-20 |
| |
Prospective randomized comparative study of single incision laparoscopiccholecystectomy versus conventional four-port laparoscopic cholecystectomy.
Lai EC, Yang GP, Tang CN, Yih PC, Chan OC, Li MK., Am J Surg. 2011 Sep;202(3):254-8. |
| |
Pain persists in many patients five years after removal of the gallbladder: observations from two randomized controlled trials of symptomatic, noncomplicated gallstone disease and acute cholecystitis.
M Vetrhus, T Berhane, O Søreide, K Søndenaa, J Gastrointest Surg. 2005 Jul-Aug:826-31 |
| |
Somatosensory changes in the referred pain area before and after cholecystectomy in patients with uncomplicated gallstone disease.
M Stawowy, AM Drewes, L Arendt-Nielsen, P Funch-Jensen, Scand J Gastroenterol. 2006 Jul:833-7 |
| |
Gallstones increase the prevalence of Barrett's esophagus.
Matsuzaki J, Suzuki H, Asakura K, Saito Y, Hirata K, Takebayashi T, Hibi T, J Gastroenterol. 2010 Feb;45(2):171-8 |
| |
| Supplementary evidence: |
| |
Vitamin C supplement use may protect against gallstones: an observational study on a randomly selected population.
Walcher T, Haenle MM, Kron M, Hay B, Mason RA, Walcher D, Steinbach G, Kern P, Piechotowski I, Adler G, Boehm BO, Koenig W, Kratzer W, EMIL study group, BMC Gastroenterol. 2009 Oct 8;9:74 |